IDSA : 1020 Splash Page

Tom Dukes : A healthy and active father in Southern California whose life was torn apart by a painful and drug-resistant E. coli infection. Read his story
“I’ve got some bad news,” said the emergency room doctor that night in late 2009. “You’re not going home tonight. You’re going to the operating room right now.”
Tom Dukes
Addie Rerecich : A healthy 11-year-old girl from Tucson, Ariz., who spent months in the hospital fighting several antibiotic-resistant infections and needed a lung transplant to save her life. Read her story or Watch the video
Addie will never be the same again, and there’s nothing I can do about it. I thought this as I sat in the hospital watching my 11-year-old daughter’s health rapidly fade. She had tubes running all over her body, a special machine had been brought in to help her breathe, and doctors were preparing me for the worst.
Tonya Rerecich, Addie's mom
Brock Wade : An active, sports-driven 9-year-old boy survives a terrifying invasive infection and pneumonia caused by MRSA. Read his story
"Everything the doctors said to me seemed to be preparing me for the worst. Brock underwent five invasive surgeries, on his shoulder and in his chest to remove the fluid putting pressure on his lungs, heart, and other vital organs."

Ronda Bailey-Wade, Brock's mom
Carlos Don : A healthy 12-year old athlete from Southern California who died of pneumonia caused by an MRSA infection. Read his story
A disease I had never heard of was killing my child. For two weeks we watched Carlos deteriorate before our eyes, praying for a miracle with every X-ray taken of his lungs.
Amber Don, Carlos' mom
Nicholas Johnson: A healthy 12-year-old from Texas who nearly died from an MRSA infection. Read his story
The hospital report says: It’s a miracle he survived.
Janet Johnson, Nicholas' mom

About the 10 x '20 Initiative
Patients are dying from drug-resistant infections that used to be treatable. Though new antibiotics are desperately needed, pharmaceutical companies are withdrawing from the antibiotics market because of the low return on investment and the difficult regulatory environment. The 10 x '20 Initiative is a global effort to foster development of 10 innovative antibiotics by 2020, sponsored by the Infectious Diseases Society of America.
Learn about the 10 x '20 initiative>>
You Can Help
Urge Congress to enact important legislation to spur research and development of new antibiotics and create a new pathway for FDA approval.

Share your own patient story with us.
Endorse the 10 x '20 Initiative
Numerous medical societies, patient groups, and other organizations have endorsed the 10 x '20 Initiative.
Please join us!
More from IDSA
10 x '20 Initiative Statement (2010)
"Bad Bugs, No Drugs" Report (2004)
"Combating Antimicrobial Resistance" Report (2011)
State-Specific Resistance Fact Sheets
Antimicrobial Resistance Policy Efforts
Contact Us
Robert Guidos
Policy & Government Contact
(703) 299- 0200
John Heys
(703) 299- 0412